530 related articles for article (PubMed ID: 23719722)
1. Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence.
Freiherr J; Hallschmid M; Frey WH; Brünner YF; Chapman CD; Hölscher C; Craft S; De Felice FG; Benedict C
CNS Drugs; 2013 Jul; 27(7):505-14. PubMed ID: 23719722
[TBL] [Abstract][Full Text] [Related]
2. Brain insulin signaling and Alzheimer's disease: current evidence and future directions.
Schiöth HB; Craft S; Brooks SJ; Frey WH; Benedict C
Mol Neurobiol; 2012 Aug; 46(1):4-10. PubMed ID: 22205300
[TBL] [Abstract][Full Text] [Related]
3. Intranasal insulin as a therapeutic option in the treatment of cognitive impairments.
Benedict C; Frey WH; Schiöth HB; Schultes B; Born J; Hallschmid M
Exp Gerontol; 2011; 46(2-3):112-5. PubMed ID: 20849944
[TBL] [Abstract][Full Text] [Related]
4. Intranasal insulin treatment improves memory and learning in a rat amyloid-beta model of Alzheimer's disease.
Farzampour S; Majdi A; Sadigh-Eteghad S
Physiol Int; 2016 Sep; 103(3):344-353. PubMed ID: 28229638
[TBL] [Abstract][Full Text] [Related]
5. Intranasal insulin improves cognition and modulates beta-amyloid in early AD.
Reger MA; Watson GS; Green PS; Wilkinson CW; Baker LD; Cholerton B; Fishel MA; Plymate SR; Breitner JC; DeGroodt W; Mehta P; Craft S
Neurology; 2008 Feb; 70(6):440-8. PubMed ID: 17942819
[TBL] [Abstract][Full Text] [Related]
6. Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice.
Chen Y; Zhao Y; Dai CL; Liang Z; Run X; Iqbal K; Liu F; Gong CX
Exp Neurol; 2014 Nov; 261():610-9. PubMed ID: 24918340
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with intranasal insulin ameliorates cognitive impairment, tau hyperphosphorylation, and microglial activation in a streptozotocin-induced Alzheimer's rat model.
Guo Z; Chen Y; Mao YF; Zheng T; Jiang Y; Yan Y; Yin X; Zhang B
Sci Rep; 2017 Apr; 7():45971. PubMed ID: 28382978
[TBL] [Abstract][Full Text] [Related]
8. Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial.
Craft S; Claxton A; Baker LD; Hanson AJ; Cholerton B; Trittschuh EH; Dahl D; Caulder E; Neth B; Montine TJ; Jung Y; Maldjian J; Whitlow C; Friedman S
J Alzheimers Dis; 2017; 57(4):1325-1334. PubMed ID: 28372335
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Insulin for Alzheimer's Disease.
Hallschmid M
CNS Drugs; 2021 Jan; 35(1):21-37. PubMed ID: 33515428
[TBL] [Abstract][Full Text] [Related]
10. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
Zemva J; Schubert M
CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
[TBL] [Abstract][Full Text] [Related]
11. Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults.
Reger MA; Watson GS; Green PS; Baker LD; Cholerton B; Fishel MA; Plymate SR; Cherrier MM; Schellenberg GD; Frey WH; Craft S
J Alzheimers Dis; 2008 Apr; 13(3):323-31. PubMed ID: 18430999
[TBL] [Abstract][Full Text] [Related]
12. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy.
Wong CYJ; Baldelli A; Hoyos CM; Tietz O; Ong HX; Traini D
Drug Deliv Transl Res; 2024 Jul; 14(7):1776-1793. PubMed ID: 38441832
[TBL] [Abstract][Full Text] [Related]
13. Intranasal insulin alleviates cognitive deficits and amyloid pathology in young adult APPswe/PS1dE9 mice.
Mao YF; Guo Z; Zheng T; Jiang Y; Yan Y; Yin X; Chen Y; Zhang B
Aging Cell; 2016 Oct; 15(5):893-902. PubMed ID: 27457264
[TBL] [Abstract][Full Text] [Related]
14. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats.
Rajasekar N; Nath C; Hanif K; Shukla R
Mol Neurobiol; 2017 Oct; 54(8):6507-6522. PubMed ID: 27730514
[TBL] [Abstract][Full Text] [Related]
15. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
[TBL] [Abstract][Full Text] [Related]
16. Sex and ApoE genotype differences in treatment response to two doses of intranasal insulin in adults with mild cognitive impairment or Alzheimer's disease.
Claxton A; Baker LD; Wilkinson CW; Trittschuh EH; Chapman D; Watson GS; Cholerton B; Plymate SR; Arbuckle M; Craft S
J Alzheimers Dis; 2013; 35(4):789-97. PubMed ID: 23507773
[TBL] [Abstract][Full Text] [Related]
17. Intranasal insulin in Alzheimer's disease: Food for thought.
Chapman CD; Schiöth HB; Grillo CA; Benedict C
Neuropharmacology; 2018 Jul; 136(Pt B):196-201. PubMed ID: 29180222
[TBL] [Abstract][Full Text] [Related]
18. The Rationale for Insulin Therapy in Alzheimer's Disease.
Ribarič S
Molecules; 2016 May; 21(6):. PubMed ID: 27240327
[TBL] [Abstract][Full Text] [Related]
19. Intranasal insulin.
Hallschmid M
J Neuroendocrinol; 2021 Apr; 33(4):e12934. PubMed ID: 33506526
[TBL] [Abstract][Full Text] [Related]
20. Intranasal Insulin Improves Age-Related Cognitive Deficits and Reverses Electrophysiological Correlates of Brain Aging.
Maimaiti S; Anderson KL; DeMoll C; Brewer LD; Rauh BA; Gant JC; Blalock EM; Porter NM; Thibault O
J Gerontol A Biol Sci Med Sci; 2016 Jan; 71(1):30-9. PubMed ID: 25659889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
